Edition:
India

Moleculin Biotech Inc (MBRX.OQ)

MBRX.OQ on NASDAQ Stock Exchange Capital Market

0.81USD
21 Sep 2020
Change (% chg)

-- (--)
Prev Close
$0.81
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
351,108
52-wk High
$1.97
52-wk Low
$0.32

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.09 December 22 Sep 2020

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 2 2 2 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.67 1.67 1.67 1.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-20 2 0.00 0.00 0.00 --
Quarter Ending Dec-20 2 0.00 0.00 0.00 --
Year Ending Dec-20 2 0.00 0.00 0.00 0.00
Year Ending Dec-21 2 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Sep-20 3 -0.09 -0.08 -0.09 --
Quarter Ending Dec-20 3 -0.09 -0.07 -0.10 --
Year Ending Dec-20 3 -0.30 -0.27 -0.32 -0.41
Year Ending Dec-21 3 -0.37 -0.30 -0.43 -0.41

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-20 0.00 0.00 0.00 0.00
Quarter Ending Dec-19 0.00 0.00 0.00 0.00
Quarter Ending Sep-19 0.00 0.00 0.00 0.00
Quarter Ending Jun-19 0.00 0.00 0.00 0.00
Quarter Ending Mar-19 0.00 0.00 0.00 0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-20 0.00 0.00 0.00 0.00 --
Quarter Ending Dec-20 0.00 0.00 0.00 0.00 --
Year Ending Dec-20 0.00 0.00 0.00 0.00 0.00
Year Ending Dec-21 0.00 0.00 0.00 0.00 0.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-20 0 0 0 0
Quarter Ending Dec-20 0 0 0 0
Year Ending Dec-20 0 0 0 0
Year Ending Dec-21 0 0 0 0
Earnings